Upperton, a leading contract development and manufacturing organization (CDMO) based in Nottingham, UK, has announced its participation in DCAT Week 2025. This premier event for companies in the pharmaceutical development and manufacturing value chain will be held in New York City from March 16 to 19.
Nikki Whitfield, CEO, and Ian Lafferty, CTO, will represent Upperton during the event. They aim to showcase Upperton’s capabilities as an integrated CDMO, supporting small to medium-sized biotech and pharmaceutical innovators. With expertise in oral, nasal, and pulmonary drug delivery, Upperton is poised to highlight its services tailored for seamless project transitions from preclinical to late stage development.
Upperton will be available for meetings within the official DCAT space at The Lexington Hotel, offering a prime opportunity to discuss collaborative possibilities with industry stakeholders.
Chief Technical Officer, Ian Lafferty, adds: “Our first time at DCAT Week provides a great networking opportunity with peers and industry professionals. We’re looking forward to showcasing our facility, and expertise and meeting new clients to support their CMC requirements across oral, nasal, pulmonary and parenteral delivery routes.”
DCAT Week is recognized globally as a key networking and business development event, bringing together leaders from across the bio/pharmaceutical manufacturing value chain. Upperton’s participation reinforces its commitment to driving innovation and forging valuable partnerships within the industry.
For more information about DCAT Week, visit the official DCAT website. To arrange a meeting with Upperton visit their official website.
Book a meeting in New York at DCAT Week 2025
Meet with our CEO Nikki Whitfield and CTO Ian Laffery to discuss your drug development goals and discover a CDMO like no other.
